About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Oncology Research Institute
›
top-articles
Oncology Research Institute
56
(top 2%)
papers
2.9K
(top 1%)
citations
29
(top 1%)
h
-index
52
(top 1%)
g
-index
56
all documents
3.0K
doc citations
982
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast Cancer
Molecular and Cellular Proteomics
2005
267
2
Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia
Oncogene
2004
248
3
Function of the SIRT1 protein deacetylase in cancer
Biotechnology Journal
2007
216
4
TheIn VitroCytotoxicity of Ascorbate Depends on the Culture Medium Used to Perform the Assay and Involves Hydrogen Peroxide
Antioxidants and Redox Signaling
2001
197
5
Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population
Clinical Pharmacology and Therapeutics
2006
130
6
RUNX3 Cooperates with FoxO3a to Induce Apoptosis in Gastric Cancer Cells
Journal of Biological Chemistry
2006
124
7
Potential roles for the PIM1 kinase in human cancer – A molecular and therapeutic appraisal
European Journal of Cancer
2008
123
8
Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
Annals of Oncology
2008
118
9
Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis
Oncogene
2011
108
10
Detection of BRAF V600E mutation by pyrosequencing
Pathology
2008
88
11
Mining the Tumor Phosphoproteome for Cancer Markers
Clinical Cancer Research
2005
81
12
Superoxide anion inhibits drug-induced tumor cell death
FEBS Letters
1999
78
13
Runx1Protects Hematopoietic Stem/Progenitor Cells from Oncogenic Insult
Stem Cells
2007
74
14
Secreted Frizzled-Related Protein 1 Extrinsically Regulates Cycling Activity and Maintenance of Hematopoietic Stem Cells
Cell Stem Cell
2009
71
15
RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression
Breast Cancer Research and Treatment
2009
69
16
Proteomics of breast cancer: Enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors
Proteomics
2005
65
17
Wnt signaling is required for organization of the lens fiber cell cytoskeleton and development of lens three-dimensional architecture
Developmental Biology
2008
65
18
Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients
Lung Cancer
2009
59
19
The Transcription Factor Runx3 Represses the Neurotrophin Receptor TrkB during Lineage Commitment of Dorsal Root Ganglion Neurons
Journal of Biological Chemistry
2007
58
20
Proteomic analysis of rabbit tear fluid: Defensin levels after an experimental corneal wound are correlated to wound closure
Proteomics
2007
57
21
Evidence for Disease Control with Erlotinib after Gefitinib Failure in Typical Gefitinib-Sensitive Asian Patients with Non-small Cell Lung Cancer
Journal of Thoracic Oncology
2008
56
22
Chelerythrine Induces Apoptosis through a Bax/Bak-independent Mitochondrial Mechanism
Journal of Biological Chemistry
2008
53
23
Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas
Journal of Cancer Research and Clinical Oncology
2009
45
24
Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer
European Journal of Cancer
2009
44
25
Detection of Epidermal Growth Factor Receptor Variations by Partially Denaturing HPLC
Clinical Chemistry
2007
41
26
Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice
British Journal of Haematology
2005
39
27
Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
Oncogene
2005
37
28
RhoA protein expression correlates positively with degree of malignancy in astrocytomas
Neuroscience Letters
2006
29
29
Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment
Biochemical Pharmacology
2007
29
30
Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours
British Journal of Cancer
2007
27
31
Runx3 expression in gastrointestinal tract epithelium: resolving the controversy
Oncogene
2009
27
32
Increased Dosage of the RUNX1/AML1 Gene: A Third Mode of RUNX Leukemia?
Critical Reviews in Eukaryotic Gene Expression
2005
27
33
Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics
Molecular Cancer Therapeutics
2007
24
34
cDNA cloning of Runx family genes from the pufferfish (Fugu rubripes)
Gene
2007
22
35
A Case for Integrated Morphomolecular Diagnostic Pathologists
Clinical Chemistry
2007
21
36
TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery
Pathology
2008
20
37
Mutational hotspot in Exon 20 of PIK3CA in breast cancer among singapore chinese
Cancer Biology and Therapy
2006
19
38
The novel RUNX3/p33 isoform is induced upon monocyte-derived dendritic cell maturation and downregulates IL-8 expression
Immunobiology
2010
19
39
BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients
Cancer Letters
2009
18
40
Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia
Blood
2007
15
41
Cofilin immunolabelling correlates with depth of invasion in gastrointestinal endocrine cell tumors
Acta Histochemica
2010
12
42
Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer
Journal of Cancer Research and Clinical Oncology
2005
10
43
Identification of marker genes including RUNX3 (AML2) that discriminate between different myeloproliferative neoplasms and normal individuals
Leukemia
2008
9
44
RUNX and cancer
Annals of the Academy of Medicine, Singapore
2003
7
45
Genetic evidence of PEBP2β-independent activation of Runx1 in the murine embryo
International Journal of Hematology
2008
5
46
The relevance of molecular diagnostics in the practice of surgical pathology
Expert Opinion on Medical Diagnostics
2008
5
47
Denaturing High Performance Liquid Chromatography for the Detection of Microsatellite Instability Using Bethesda and Pentaplex Marker Panels
Diagnostic Molecular Pathology
2008
5
48
Molecular-assisted immunohistochemical optimization
Acta Histochemica
2010
5
49
Science lessons
Nature
2005
4
50
CC3/TIP30 expression was strongly associated with HER-2/NEU status in breast cancer
Annals of the Academy of Medicine, Singapore
2004
4
site/software ©
exaly
; All materials licenced under
CC by-SA
.